Exane Derivatives’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DVA
GCM
Exane Derivatives's DVA Position: Q2 2022 in Review
Exane Derivatives held its DaVita (DVA) position steady in Q2 2022 at 2 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #692.
Exane Derivatives first reported a position in DVA in Q2 2020 and has held it in 9 quarters since. The position peaked at $493K in Q3 2020. 462 funds tracked by Wall St. Rank hold DVA as of Q2 2022.
- Exane Derivatives held 2 shares of DaVita worth $160 as of Q2 2022.
- Exane Derivatives left its DaVita share count unchanged in Q2 2022.
- DaVita made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #692 holding.
- Exane Derivatives first reported a position in DaVita in Q2 2020 and has held it in 9 quarters since.
- Exane Derivatives's DaVita position peaked at $493K in Q3 2020.
- 462 funds tracked by Wall St. Rank held DaVita as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.